SIRT1 and lip and oral cavity carcinoma: At the nucleus, SIRT1 attaches to the promoter region of TGF- β, inhibits CBP/p300-mediated acetylation and leads to transcriptional suppression of TGF- β-mediated oral cancer progression (Islam et al., 2019).